Abstract A poly(amidoamine) (PAA) copolymer with β-cyclodextrin was obtained by polyaddition reaction of 6-deoxy-6-amino-β-cyclodextrin (β-CDNH2) and 2-methylpiperazine to 2,2-bis(acrylamido)acetic acid in aqueous medium. This β-CD/PAA copolymer bears β-CD units along the macromolecular chain, is water-soluble and non-cytotoxic. The complexing capacity of β-CD/PAA was determined using an antiviral drug, Acyclovir, as a model of poorly water-soluble drug. Complex formation was confirmed by means of DSC and FTIR analyses. β-CD/PAA can solubilize up to 11% w/w of Acyclovir notably increasing the aqueous solubility of the drug. The in vitro release studies showed the dependence of Acyclovir release rate on the solution pH. The antiviral activity of Acyclovir β-CD/PAA complex was evaluated against herpes simplex virus type I in cell cultures. The Acyclovir β-CD/PAA complex exhibited a higher antiviral activity than the free drug

Preparation and in vitro evaluation of the antiviral activity of the acyclovir complex of a B-cyclodextrin/poly(amidoamine) copolymer

TROTTA, Francesco;DONALISIO, Manuela;LEMBO, David;CAVALLI, Roberta
2008

Abstract

Abstract A poly(amidoamine) (PAA) copolymer with β-cyclodextrin was obtained by polyaddition reaction of 6-deoxy-6-amino-β-cyclodextrin (β-CDNH2) and 2-methylpiperazine to 2,2-bis(acrylamido)acetic acid in aqueous medium. This β-CD/PAA copolymer bears β-CD units along the macromolecular chain, is water-soluble and non-cytotoxic. The complexing capacity of β-CD/PAA was determined using an antiviral drug, Acyclovir, as a model of poorly water-soluble drug. Complex formation was confirmed by means of DSC and FTIR analyses. β-CD/PAA can solubilize up to 11% w/w of Acyclovir notably increasing the aqueous solubility of the drug. The in vitro release studies showed the dependence of Acyclovir release rate on the solution pH. The antiviral activity of Acyclovir β-CD/PAA complex was evaluated against herpes simplex virus type I in cell cultures. The Acyclovir β-CD/PAA complex exhibited a higher antiviral activity than the free drug
JOURNAL OF CONTROLLED RELEASE
126
17
25
Acyclovir; Herpes simplex virus
M. Bencini; E. Ranucci; P. Ferruti; F. Trotta; M. Donalisio; M. Cornaglia; D. Lembo; R. Cavalli
File in questo prodotto:
File Dimensione Formato  
Bencini et al 2008.pdf

non disponibili

Descrizione: Articolo principale
Tipo di file: PDF EDITORIALE
Dimensione 488.72 kB
Formato Adobe PDF
488.72 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/99471
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 41
  • ???jsp.display-item.citation.isi??? 34
social impact